Biogen To Invest $200 M for a New Gene-Therapy Mfg Facility
Biogen has announced plans to build a new gene-therapy manufacturing facility at its Research Triangle Park manufacturing campuses in North Carolina.
Through the new facility, Biogen aims to expand its existing operations and combined workforce of approximately 1,900 employees at both campuses in Research Triangle Park. Biogen anticipates that the new facility will create approximately 90 new jobs, with an estimated total investment of approximately $200 million.
The site will be 175,000 square feet and designed in compliance sustainability standards regarding energy use, waste management, and water consumption.